All three scoring criteria have been used: - ASCO / CAP HER2 Breast Cancer 2018 - CAP / ASCP / ASCO HER2 Gastroesophageal Adenocarcinoma 2016 (aka Ventana) - HERACLES (listed in this protocol)
The HERACLES criteria of HER2 POSITIVE: 3+ HER2 IHC score in more than 50% of the tumor cells OR 3+ HER2 IHC score in 10~50% of the tumor cells by IHC + FISH/DISH positive OR 2+ HER2 IHC score in more than 50% of the tumor cells by IHC + FISH/DISH positive Lancet Oncol 2016 17(6):738–746.
- Additional notes: